Tech Company Financing Transactions

Tenpoint Therapeutics Funding Round

On 1/29/2026, Tenpoint Therapeutics raised $235 million in Series B investment from British Business Bank, EQT Growth and Hillhouse Capital Group.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

30 Broad Street, Great Cambourne
Cambridge, England, CB23 6HJ
UK

Phone

Undisclosed

Website

www.tenpointtherapeutics.com

Email Address

[email protected]

Overview

We are developing engineered cell-based therapeutics and in vivo reprogramming to reverse vision loss caused by deterioration of functional tissue.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Eddy Anglade

        

Chief Technical Officer

Gabriella Rolli

        

Founder

Pete Coffey

        

Founder

Thomas Reh

        

Browse more venture capital transactions:

Prev: 1/29/2026: Sound Games venture capital transaction
Next: 1/29/2026: Robco venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary